| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.11▲ | 1.11▲ | 1.12▲ | 1.22▼ | 1.42▼ |
| MA10 | 1.11▲ | 1.11▲ | 1.10▲ | 1.35▼ | 1.49▼ |
| MA20 | 1.11▲ | 1.11▲ | 1.16▼ | 1.40▼ | 1.88▼ |
| MA50 | 1.10▲ | 1.20▼ | 1.30▼ | 1.51▼ | 27.23▼ |
| MA100 | 1.15▼ | 1.32▼ | 1.38▼ | 1.93▼ | 23.64▼ |
| MA200 | 1.25▼ | 1.39▼ | 1.45▼ | 14.30▼ | 37.73▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.009▲ | 0.007▲ | -0.033▼ | 1.410▲ |
| RSI | 62.561▲ | 46.994▼ | 38.526▼ | 31.962▼ | 35.533▼ |
| STOCH | 50.397 | 86.458▲ | 62.134 | 11.055▼ | 12.747▼ |
| WILL %R | 0.000▲ | 0.000▲ | -56.410 | -82.692▼ | -94.611▼ |
| CCI | 130.212▲ | 119.577▲ | 12.111 | -178.130▼ | -176.171▼ |
|
Monday, November 10, 2025 03:06 AM
First data on Aptevo's new molecule presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting ...
|
|
Monday, November 03, 2025 09:05 AM
(Reuters) -AstraZeneca shareholders approved a direct listing of the drugmaker's shares on the New York Stock Exchange on Monday, giving it access to a deeper capital pool. The drugmaker said 99.36% ...
|
|
Wednesday, June 11, 2025 05:14 AM
AML across two trialsIntroduces first trispecific molecules, APVO451 and APVO452, advancing therapies designed ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 21/11/25 | 1.10 | 1.14 | 1.04 | 1.13 | 949,901 |
| 20/11/25 | 1.25 | 1.25 | 1.07 | 1.08 | 991,257 |
| 19/11/25 | 1.30 | 1.31 | 1.21 | 1.22 | 673,151 |
| 18/11/25 | 1.34 | 1.35 | 1.27 | 1.32 | 818,905 |
| 17/11/25 | 1.40 | 1.425 | 1.35 | 1.37 | 508,281 |
| 14/11/25 | 1.41 | 1.43 | 1.38 | 1.41 | 711,617 |
| 13/11/25 | 1.52 | 1.54 | 1.415 | 1.45 | 691,823 |
| 12/11/25 | 1.49 | 1.505 | 1.45 | 1.48 | 452,602 |
| 11/11/25 | 1.51 | 1.53 | 1.475 | 1.50 | 486,521 |
| 10/11/25 | 1.48 | 1.56 | 1.44 | 1.56 | 1,193,921 |
|
|
||||
|
|
||||
|
|